NovelmiRNA-25 inhibits AMPD2 in peripheral blood mononuclear cells of patients with systemic lupus erythematosus and represents a promising novel biomarker

BACKGROUND: Systemic lupus erythematosus (SLE) is a multisystemic autoimmune disease with various clinical manifestations. MicroRNAs (miRNAs) and immunometabolism are recognized as key elements in SLE pathogenesis; however, the relationship between miRNAs in peripheral blood mononuclear cells (PBMCs...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Gangqiang, Wang, Huijing, Shi, Xinyu, Ye, Lele, Wu, Kai, Lin, Kangmin, Ye, Sisi, Li, Baoqing, Zhang, Huidi, Lin, Qiaoai, Ye, Shuang, Xue, Xiangyang, Chen, Chaosheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303892/
https://www.ncbi.nlm.nih.gov/pubmed/30577810
http://dx.doi.org/10.1186/s12967-018-1739-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303892/
https://www.ncbi.nlm.nih.gov/pubmed/30577810
http://dx.doi.org/10.1186/s12967-018-1739-5

Ejemplares similares